NAFLD Fibrosis Score
Use
The NAFLD Fibrosis Score is a validated, noninvasive tool to identify patients with nonalcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction‑associated steatotic liver disease (MASLD), who may have advanced liver fibrosis. It combines selected laboratory values—serum glucose, platelet count, AST, ALT, albumin—with patient characteristics such as age, body mass index, and diabetes status to assess fibrosis risk; scores above 0.676 indicate likely advanced fibrosis, while those below −1.455 exclude advanced fibrosis, with intermediate values considered indeterminate.
Special Instructions
Not provided.
Limitations
The NAFLD Fibrosis Score may overestimate risk in certain populations, such as patients with obesity or type 2 diabetes mellitus, and thus may not be appropriate for use in primary care settings.
Methodology
Automated Analyzer (Other)
Biomarkers
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Serum separator tube (SST)
Patient Preparation
Fasting preferred (at least 8 hours)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 5 days |
Other tests from different labs that may be relevant